España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Teva Pharmaceutical Indus
TEVA
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Teva Pharmaceutical Indus (TEVA) Forecast
News
Earnings
Teva Pharmaceutical Indus (TEVA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Teva Pharmaceutical Indus (NYSE:TEVA) Stock
Teva Pharmaceutical Indus Stock (NYSE: TEVA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Saturday, November 16, 2024
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Juan Spínelli
Thursday, November 07, 2024
Market Whales and Their Recent Bets on TEVA Options
Benzinga Insights
Wednesday, November 06, 2024
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
Vandana Singh
Teva Pharmaceutical CEO Francis Says Expects ...
Benzinga Newsdesk
Teva shares are trading higher after the comp...
Benzinga Newsdesk
Teva Forecasts 2024 Revenues Of $16.1B-$16.5B...
Benzinga Newsdesk
Teva Forecasts 2024 Adjusted EPS Of $2.40-$2....
Benzinga Newsdesk
Teva Pharmaceutical Indus Q3 2024 Adj EPS $0....
Benzinga Newsdesk
Friday, November 01, 2024
Teva Presents New Tardive Dyskinesia Data At ...
Benzinga Newsdesk
Teva Presents Latest Schizophrenia Treatment ...
Benzinga Newsdesk
Tuesday, October 29, 2024
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today
Benzinga Insights
Wednesday, October 23, 2024
A Closer Look at 4 Analyst Recommendations For Teva Pharmaceutical Indus
Benzinga Insights
Barclays Maintains Overweight on Teva Pharmac...
Benzinga Newsdesk
Tuesday, October 22, 2024
Alvotech, Teva Reports FDA Approval For SELAR...
Benzinga Newsdesk
Monday, October 21, 2024
JP Morgan Maintains Neutral on Teva Pharmaceu...
Benzinga Newsdesk
Thursday, October 17, 2024
Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
Vandana Singh
Amicus Therapeutics Enters License Agreement ...
Benzinga Newsdesk
Friday, October 11, 2024
Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes
Vandana Singh
Thursday, October 10, 2024
'Drug Maker Teva Pharmaceuticals Agrees to Pa...
Benzinga Newsdesk
Here's How Much $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today
Benzinga Insights
Tuesday, October 08, 2024
Teva Says FDA Has Accepted, And The European ...
Benzinga Newsdesk
Monday, October 07, 2024
US State Of Georgia's Supreme Court Reinstate...
Benzinga Newsdesk
Thursday, October 03, 2024
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Vandana Singh
Teva And mAbxience Expand Strategic Partnersh...
Benzinga Newsdesk
Tuesday, October 01, 2024
Teva Launches Generic Version Of Sandostatin In The US
Vaishali Prayag
Teva Announces Launch Of The First And Only G...
Benzinga Newsdesk
Monday, September 30, 2024
$1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast
Vandana Singh
Monday, September 23, 2024
Reported Saturday, Teva Unveils Data on UZEDY...
Benzinga Newsdesk
Reported Saturday, Teva's New Schizophrenia T...
Benzinga Newsdesk
Reported Earlier, Teva Pharmaceutical Disclos...
Benzinga Newsdesk
Monday, September 16, 2024
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today
Benzinga Insights
Thursday, September 12, 2024
North Dakota Judge Overturns State's Abortion...
Benzinga Newsdesk
Wednesday, September 11, 2024
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Vandana Singh
Tuesday, September 10, 2024
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Vandana Singh
Teva Set To Be Fined By EU Antitrust Regulato...
Benzinga Newsdesk
Monday, September 09, 2024
Apple Announces New Sleep Apnea Features On A...
Benzinga Newsdesk
Friday, September 06, 2024
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
Vandana Singh
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Vandana Singh
Tuesday, September 03, 2024
Key Takeaways From Teva Pharmaceutical Indus Analyst Ratings
Benzinga Insights
UBS Maintains Buy on Teva Pharmaceutical Indu...
Benzinga Newsdesk
Friday, August 23, 2024
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
Vandana Singh
Wednesday, August 21, 2024
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
Benzinga Insights
Wednesday, August 14, 2024
Spotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity
Benzinga Insights
Tuesday, August 13, 2024
$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
Thursday, August 01, 2024
Barclays Maintains Overweight on Teva Pharmac...
Benzinga Newsdesk
Wednesday, July 31, 2024
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
Piero Cingari
Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales
Vandana Singh
Teva Pharmaceuticals Industries shares are tr...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch